Inc. - Empowering the Individual Investor Online financial quotes, charts and technical
analysis for stock and commodity traders.
Links: Quote | Chart | Opinion | Profile |
VIROPHARMA - Fundamental Profile
Company Information
Ticker Symbol: VPHM
Exchange: NASD
Contact Info: 730 STOCKTON DRIVE
EXTON PA 19341
CEO/President: Vincent J. Milano
SIC: 2834, Medical - Drugs
Description: ViroPharma Incorporated is an international biopharmaceutical company focused on developing and commercializing products for physician specialists or in hospital settings. The Company's marketed products include Cinryze TM and Vancocin'. Cinryze is a C1 esterase inhibitor therapy for routine prophylaxis against hereditary angioedema (HAE), also known as C1 inhibitor (C1-INH) deficiency, a rare, severely debilitating, life-threatening genetic disorder. Vancocin is a potent antibiotic to treat antibiotic-associated pseudomembranous colitis caused by Clostridium difficile infection (CDI), or C. difficile, and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains. ViroPharma currently focuses its drug development activities in diseases including C1 esterase inhibitor deficiency and C. difficile. The Company sells its products directly to wholesale drug distributors, and specialty pharmacies/specialty distributors. ViroPharma Incorporated is headquartered in Exton, Pennsylvania.

Share Information
Market Value, $K: 3,296,370 Shares Outstanding, K: 65,520
% Held by Insiders: 5.20% % Institutional Shareholders: N/A%
Last Quarter Sales, $M: 113.06 Last Quarter Net Income, $M: 4.19
Last Quarter EPS: 0.19 P/E Ratio: 124.93
Annual EPS, $: 0.40 Most Recent Earnings, $: 0.20 on 10/31/13
Annual Dividend Rate, $: 0 Most Recent Dividend:
Annual Dividend Yield, %: 0% Most Recent Split:

Fundamental information provided by Zacks Investment Research, Inc. Zacks does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the Zacks content provided hereunder, or for any delay in reporting such data. Zacks expressly disclaims all warranties of fitness of the Zacks content or computations and analyses thereof for a particular purpose or use.

Enter Symbol:    
Quote Chart Opinion Profile
Data provided by ddfplus and subject to terms of use. Copyright © 1995 - 2014 Inc. User agreement applies.
All Equities data is delayed according to exchange rules. Futures data is end of day.
NYSE, AMEX and Nasdaq at least 15 minutes.